Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Ledipasvir + Sofosbuvir). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Ledipasvir + Sofosbuvir is used to treat chronic hepatitis C (CHC) caused by genotype 1 infection in adults.
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Recommended dosage: one tablet (90 mg of Ledipasvir and 400 mg of Sofosbuvir) taken by mouth once daily, with or without food. Recommended treatment duration: 12 weeks for treatment-naive patients with or without cirrhosis, 12 weeks for treatment-experienced patients without cirrhosis, and 24 weeks for treatment-experienced patients with cirrhosis. No dosage recommendation can be made for patients with severe renal impairment or end-stage renal disease.
পার্শ্বপ্রতিক্রিয়া
Fatigue, headache, nausea, diarrhoea and insomnia are the most commonly reported side effects with this tablet, each seen in 10% or more of patients (across all severity grades) taking it for 8, 12, or 24 weeks.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Bradycardia with amiodarone coadministration: Patients taking amiodarone may experience serious symptomatic bradycardia, particularly if they are also on beta-blockers or have underlying cardiac conditions and/or advanced liver disease. Taking amiodarone together with this tablet is not recommended. For patients who have no other viable treatment option, cardiac monitoring is advised. Using this medicine with other drugs containing sofosbuvir is also not recommended.
নিষেধাজ্ঞা
This combination should not be used in patients who are known to be hypersensitive to ledipasvir, sofosbuvir, or any other ingredient in the product.